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Purpose: To compare the outcome of percutaneous nephrolithotomy (PCNL) using split or intact Amplatz sheath.
Materials and Methods: Seventy two patients who underwent PCNL were randomly divided into two groups; 
PCNL using intact (group 1) and split (group 2) Amplatz sheath. Preoperative data, operative time, largest extracted 
stone size, fluoroscopy and lithotripsy time, and serum biochemistry tests before and after PCNL were evaluated.
Results: Preoperative features and stone size were not significantly different between the groups. There were no 
significant differences in complications and postoperative changes in hemoglobin and serum electrolytes. Stone 
free rate in group 2 (88.1%) was insignificantly higher than group 1 (83.3%) (p = .05), but in staghorn stones and 
stones larger than 1000 mm2, stone free rate in group 2 was significantly higher than group 1 (82% vs. 72%). The 
mean extracted stone size in group 2 (150 ± 49mm2) was significantly larger than group 1 (40 ± 16 mm2) (p < .005). 
The mean operative, lithotripsy and fluoroscopy times were significantly longer in group 1. 
Conclusion: Using split Amplatz sheath in PCNL facilitates extraction of larger stone fragments which could 
contribute to shorter fluoroscopy, lithotripsy and operative times.
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INTRODUCTION
Percutaneous nephrolithotomy (PCNL) is the standard procedure for the treatment of stones larger than 2 
cm, staghorn calculi, and small stones refractory to shock 
wave lithotripsy (SWL).(1-3) PCNL has the highest stone-
free rate (SFR) among all renal stone treatment options. 
The SFR after one session of PCNL is more than 80%.(4)
Operative time is a key factor correlated with the post-
operative and, indirectly with anesthesia-related com-
plications.(5,6) A few studies have investigated factors 
that influence operative time during percutaneous neph-
rolithotomy. These studies have shown that a history 
of open surgery, stone size and surgical experience are 
correlated with operative time(6,7). In a study by el-Na-
has et al. stone size was found to be a predictive fac-
tor for both longer operative time and hospital stay.(8) 
We hypothesized that extraction of stones in larg-
er fragments may decrease the need for stone 
fragmentation and consequently, shorten the op-
erative time. Hence, this study was done to com-
pare the perioperative and postoperative outcome 
of PCNL using split and intact Amplatz sheath.
MATERIALS AND METHODS
Between June and April 2014, 123 patients underwent 
PCNL in our department. The study was approved by 
our institutional ethical committee, and informed con-
sent was sought from all patients. All patients who were 
candidate for PCNL were included except patients with 
The American Society of Anesthesiologists (ASA) risk 
class III or more, multiple stones and those requiring su-
pracostal access. Considering study power of 80%, sam-
ple size was calculated to be 36 patients in each group. 
We randomized patients into two groups; in group one 
PCNL was performed using intact Amplatz sheath, and 
in group two longitudinally split Amplatz sheath was 
used. To have a split Amplatz sheath, a conventional 
Amplatz sheath was simply cut longitudinally in its total 
length with a surgical knife. The randomization method 
was simple randomization using table of random num-
bers. Figure 1 shows the CONSORT chart of this study. 
Preoperative evaluation included laboratory tests (com-
plete blood count (CBC), coagulation tests, serum 
electrolytes, urine analysis and culture) and imaging 
studies (spiral abdominopelvic computed tomogra-
phy (CT) scan and/or intravenous urography (IVU). 
All patients received prophylactic antibiotics preoper-
atively. Data were collected prospectively by one of 
the authors blinded to the procedure. Participants and 
care givers were also blinded to group assignment.
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In the lithotomy position and under spinal anesthesia, 
cystoscopy was performed to insert a 5F ureteral cath-
eter. The position was changed to prone with a support 
under chest and pelvis. Access to the kidney was ob-
tained under fluoroscopic guidance; the tract was di-
lated to 30 Fr using Amplatz dilator with single-step 
dilation technique, and Amplatz sheath (split or intact 
sheath) was placed. Stone degradation was performed 
by pneumatic lithotripsy using lithoclast master system 
(EMS, Switzerland). We did not use flexible nephros-
copy for our patients. An 18 Fr nephrostomy tube was 
inserted at the end of procedure for all patients. All op-
erations were supervised by an attending endourologist.
CBC and serum electrolytes were checked on the 
first postoperative day. Abdominal ultrasonography 
and plain abdomen X-ray were also performed on the 
first postoperative day. If there was no significant re-
sidual stone, nephrostomy tube was removed. Ureter-
al catheter was removed when urinary leakage from 
nephrostomy removal site was less than 100 ml/day. 
Patients with no residual stone or residual stone < 4 
mm were considered stone free. Stone free rate was 
the primary outcome evaluated in this study. Sec-
ondary outcomes included operative time, the larg-
est extracted stone size, fluoroscopy and lithotripsy 
times, blood tests before and after PCNL, ancillary 
procedures, hospital stay and complications. For sta-
tistical analysis, SPSS ver.21 software was used. 
Quantitative and categorical variables were tested us-
ing student’s t-test and chi-square test, respectively.
RESULTS
Seventy two patients (57 men and 15 women) 
with mean age of 43.45 ± 13.41 years were included 
in the study. The preoperative characteristics were not 
significantly different between the two groups. (Ta-
ble 1) The mean body mass index (BMI) was 29.2 ± 
5.6 and 28.64 ± 6.1 Kg/m2 in group one and two, re-
spectively (p = .68). Table 2 summarizes intra- and 
 Table 1. Stones characteristics.
Stone characteristics   Intact group   Split group   Total
Stone locationa   
  Upper calyx   1   1   2
  Lower calyx   4   3   7
  Pelvis    14   13   27
  Pelvis + one calyx   10   13   23
  Staghorn   6   7   13
Mean stone sizeb (mm2)  950 ± 967   1165 ± 1424   1005.7 ± 23
aStatistically insignificant difference between the groups. (P = .58)
b P = .45
Features    Intact group  Split group  P value
Operative time (mean ± SD) min   70 ± 22.2   48.33 ± 17.32  .005
Fluoroscopy time (mean ± SD) second  45.8 ± 14.66   25.63 ± 12.8   .005
Extracted stone size (mean ± SD) mm2  40 ± 16  150 ± 49   .005
Preoperative hemoglobin (mean ± SD) g/dl  14.32 ± 1.52  14.1 ± 1.2  .67
Postoperative hemoglobin (mean ± SD) g/dl  11.8 ± 1.56  11.82 ± 2.7  .95
Preoperative Na (mean ± SD) mg/dL  141.7 ± 2.6  141.8 ± 2.6  .14
Postoperative Na (mean ± SD) mg/dL  141.1 ± 2.56  140.08 ± 3.2  .13
Preoperative K (mean ± SD) mg/dL   4.23 ± 0.22  4.34 ± 0.42  .22
Postoperative K (mean ± SD) mg/dL  4.11 ± 0.31  3.95 ± 0.36  .08
Preoperative Cr (mean ± SD) mg/dL   1.11 ± 0.22  1.11 ± 0.27  .9
Postoperative Cr (mean ± SD) mg/dL  1.13 ± 0.27  1.13 ± 0.35  .95
Hospital Stay (mean ± SD) days   3.5 ± 1.5   3.1 ± 1.2  .2
Lithotripsy time (mean ± SD) second  61.9 ± 30.69  38.61±33.58  .003
Access tracts (No. of patients)       .005
1     34  33
2     2  3 
Table 2. Intra- and postoperative data.
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postoperative data. The mean operative, fluoroscopy 
and lithotripsy times in group one (intact sheath) were 
significantly longer than group two (split sheath). The 
mean size of extracted stone fragment in group one 
was significantly smaller than group two. (Figure 2) 
Hemoglobin change was not significantly different (p 
= .54) (2.52 ± 1.2 in the split group vs. 2.35 ± 1.07 
in intact group). There was no significant difference 
in mean change of serum sodium (Na), potassium 
(K), and creatinine between the two groups. (Table 2) 
Stone free rate was not significantly different between 
the two groups (83.3% vs. 88.1% in groups 1 and 2, 
respectively) (P = .5). However, in staghorn stones and 
stones larger than 1000 mm2, stone free rate in group 1 
was significantly lower than group 2 (72% vs. 82%). 
The need  for ancillary procedures was not significantly 
different between the two groups. SWL was necessary 
in 6 patients (4 patients in group one and two patients 
in group two), ureteroscopy in two patients (one pa-
tient in each group), and repeat PCNL in two patients 
(one patient in each group). According to the modified 
Clavien system, class II complication (blood transfu-
sion) was found in 3 patients in group one and 2 pa-
tients in group two (P = .56). Class IIIa complication 
(double-J stent insertion without general anesthesia 
because of prolonged urine leakage from nephrostomy 
removal site) occurred in two patients in group 1 and 
one patient in group 2. There were no perinephric col-
lection (evaluated by ultrasonography) or major com-
plications (Clavien class IIIb or higher) in our patients. 
DISCUSSION
Since the first report of PCNL in 1976, its instruments 
and techniques have evolved. PCNL is currently the 
standard of care for large renal stones (> 2 cm)(9). Al-
though PCNL is safe and effective, it is the most costly 
minimally invasive procedure for renal stone treatment.
(10) The cost-effectiveness of PCNL correlates with op-
erative time, stone burden, stone free rate, and major 
complications.(6) Bleeding is one of the most common 
complications of PCNL, with an incidence rate of 
1-55% in different studies.(11) Operative time is an im-
portant factor that correlates with perioperative bleed-
ing and cost-effectiveness of the procedure.(6) A few 
studies are available about factors affecting operative 
time of PCNL. Olbert et al. reported on 109 patients 
who underwent PCNL and found out that stone size 
correlates with operative time and hospital stay(12). Ak-
man et al. showed that operative time for stones larger 
than 1000 mm2   was three times longer than for stones 
less than 1000 mm2. With increasing stone burden, the 
need for multiple access tracts increases and multiple 
tracts are correlated with more blood loss and longer 
hospital stay(6). Bagrodia et al. found that increasing 
Figure 1. CONSORT chart of the study.
Figure 2. A large stone fragment is extracted from the split Am-
platz sheath.
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stone size affects treatment related costs. Larger stone 
burden is associated with longer operative time, longer 
hospital stay, more salvage procedures, and higher cost. 
They also showed that average operative time slow-
ly decreases with increased experience of surgeon.(10) 
Some authors have reported that the hydronephro-
sis grade could affect operative time. They described 
that a severely hydronephrotic kidney collapses af-
ter percutaneous access and detection of stone frag-
ments could be difficult and take longer time.(6,12) 
Correlation between stone size and operative time 
could be explained by longer time needed for stone 
fragmentation and extraction. Since operative time 
affects complication rate and cost-effectiveness, 
any attempt to reduce it is of critical importance.
Our study compared the outcomes of PCNL using 
intact and split Amplatz sheath in a randomized clin-
ical trial. It showed that using split Amplatz sheath 
allows for extracting significantly larger stone frag-
ments which results in decrease of lithotripsy time and 
number of stone fragments. As the number of stone 
fragments is reduced, their detection and extraction 
could be performed easier, faster, and with less need 
for fluoroscopy. This could also explain higher stone 
free rate achieved in group 2, particularly for staghorn 
calculi and stones larger than 1000 mm2. A technical 
point of using split sheath was the risk of entrapment 
of stone fragments in the fascia. To avoid this risk, the 
fascia should be opened wider. Blood transfusion and 
mean Hb change was not significantly different be-
tween the two groups. There was concern about prob-
able fluid leakage through the split sheath and the risk 
for electrolyte disturbances. Our findings showed that 
electrolyte changes were not significantly different be-
tween the two groups and none of the patients had per-
inephric collection on postopearative ultrasonography. 
CONCLUSION
Using split Amplatz sheath during PCNL facilitates ex-
traction of larger stone fragments which could contribute 
to shorter fluoroscopy time, lithotripsy time, and opera-
tive time. Operative time is a key factor which correlates 
with intra- and postoperative complications. It seems 
that the benefits of using spit Amplatz sheath might be 
more considerable in large and staghorn stones. This 
should be confirmed in larger studies with more patients.
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